Targeting dyslipidemia--the key to CHD risk reduction in the diabetic population?
Betteridge
D John
DJ
Endocrinology and Metabolism, Department of Medicine, University College London Medical School, London, UK. j.betteridge@ucl.ac.uk
Rosenson
Robert S
RS
D002318:Cardiovascular Diseases / Q000517:prevention & control; D003327:Coronary Disease / Q000453:epidemiology* / Q000517:prevention & control; D003925:Diabetic Angiopathies / Q000453:epidemiology* / Q000517:prevention & control*; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications* / Q000517:prevention & control*; D012307:Risk Factors